Pharmacy

An FDA advisory panel endorsed Sept. 13 the first protective therapy for peanut allergies, according to STAT.

A small strip mall pharmacy in Florida was the site of a $1.2 million health insurance fraud scheme, according to the Miami Herald.

Embattled OxyContin maker Purdue Pharma filed for bankruptcy on Sept. 15, according to The New York Times. 

The Drug Enforcement Administration is proposing to set more stringent limits on the amount of opioids the U.S. is allowed to produce, according to Drug Topics.

Implementing a pharmacist-led program for HIV pre-exposure prophylaxis treatment could improve patient satisfaction and pharmacist acceptability, according to a study from Oxford University cited by Pharmacy Times.

Medical device and drug recalls, whether voluntary or forced by the FDA, ensure patient safety. Here are five reported by Becker's Hospital Review in the last two weeks:

Capsule Corp., a New York City-based online pharmacy startup, plans to expand to other large cities after raising $200 million, according to Bloomberg.

KRS Global Biotechnology, a Boca Raton, Fla.-based drug compounding facility, is recalling all lots of its unexpired human and animal drugs due to lack of sterility assurance.

Despite the new "right-to-try" law, many drugmakers still want a relevant regulatory authority to review requests from patients with life-threatening illnesses who want access to experimental drugs, according to a recent Government Accountability Office report.

Though several Big Pharma companies face a federal opioid trial next month, several have reached settlements that may allow them a sizable tax break, according to USA Today.